STENLOSE, Denmark—Fluxome A/S and GlycaNova Norway AS entered an exclusive agreement and introduced a beta-glucan product to the U.S. dietary supplement market, Fluxome® Beta Glucan. Fluxome gained the exclusive rights from GlycaNova to market and sell the beta-glucan product.
Fluxome Beta Glucan, developed by GlycaNova, is a natural beta-glucan product manufactured by fermentation. The product has been subject to a number of clinical trials, which confirmed Fluxome Beta Glucan’s immune-enhancing effects in humans.
